WNT Pathway clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • FOG-001 in Locally Advanced or Metastatic Solid Tumors

    open to eligible people ages 18 years and up

    The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

    at UCLA UCSF

Our lead scientists for WNT Pathway research studies include .

Last updated: